NCT03696875

Brief Summary

Objectives: To demonstrate the efficacy of care transition holistic intervention (Multilevel Guided Discharge Planning, MGDP) in reducing 30-day adverse outcomes among frail older patients with acute heart failure (AHF) discharged from Emergency Departments (EDs) and to validate the results of MGDP in real life. Method: Investigators will select frail patients ≥70 years with primary diagnosis of AHF discharged from EDs. The intervention will consist of MGDP implementation: 1) checklist that includes clinical recommendations and resources activations; 2) scheduling of early visit with the specialist; 3) communication with primary care; 4) providing a written instruction sheet to patient or caregiver. Phase 1: matched-pair cluster randomized clinical trial. EDs were randomly allocated to intervention (n = 10) or control (n = 10) group. Investigators will compare the outcomes between intervention and control groups. Phase 2: a quasi-experimental study. The 20 EDs will carry out the intervention. Investigators will compare the outcomes between phase 1 and phase 2 of intervention group and between phase 1 and phase 2 of control group. The main outcome is a 30-day composite endpoint (ED revisit or hospital admission for AHF and cardiovascular death) after being discharged.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,260

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 5, 2018

Completed
8 months until next milestone

Study Start

First participant enrolled

May 20, 2019

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2022

Completed
Last Updated

July 8, 2019

Status Verified

July 1, 2019

Enrollment Period

2.6 years

First QC Date

September 28, 2018

Last Update Submit

July 3, 2019

Conditions

Keywords

Discharge PlanningEmergency DepartmentHeart failureOlderFrail

Outcome Measures

Primary Outcomes (1)

  • 30-day emergency revisit or hospital admission for acute heart failure or cardiovascular mortality rate after discharge

    The proportion of patients who have emergency revisit or hospital admission for acute heart failure or cardiovascular mortality within 30 days after discharge

    at 30 days post-discharge

Secondary Outcomes (13)

  • All-cause emergency revisit rate

    at 30 days post-discharge

  • Acute heart failure emergency revisit rate

    at 30 days post-discharge

  • Cardiovascular emergency revisit rate

    at 30 days post-discharge

  • All-cause hospitalisation rate

    at 30 days post-discharge

  • Acute heart failure hospitalisation rate

    at 30 days post-discharge

  • +8 more secondary outcomes

Study Arms (2)

Multilevel Guided Discharge Planning

EXPERIMENTAL
Other: Multilevel Guided Discharge Planning

Standard of care

ACTIVE COMPARATOR
Other: Standard of care

Interventions

Clinical recommendations and resources activations + scheduling of early visit with the specialist + communication with primary care + written instruction sheet to the patient

Multilevel Guided Discharge Planning

Standard of care

Standard of care

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥70 years.
  • Diagnosis of descompensated chronic heart failure.
  • Screening for frailty positive (ISAR ≥ 2).
  • Planned discharge home from Emergency Department (included observation and short stay unit).
  • Written informed consent provided by the patient or proxy.

You may not qualify if:

  • De novo (new onset) acute heart failure (AHF).
  • Severe episode of acute heart failure (≥9th decile of MEESSI-AHF Score).
  • Uncorrected clinically significant primary valvular disease.
  • Acute coronary syndrome currently or within 30 days prior to enrolment.
  • Surgery or implanted device within 30 days prior to enrolment.
  • Significant arrhythmias.
  • Uncorrected systolic blood pressure \< 100 mmHg, O2 saturation baseline \< 92%, heart rate \< 60 or \>110 bpm, serum sodium \< 130 mmol/l, serum potassium \>5,5 mmol/l or hemoglobin \<9 g/dL prior to enrolment.
  • Planned treatment with vasoactive therapies, ventricular assist device, heart surgery or transplant within 6 months.
  • End stage renal disease.
  • Severe disability.
  • Difficulty intervention due to significant dementia, active delirium or psychiatric disorder.
  • Condition with a life expectancy \<1 year.
  • Length of stay in Emergency Department ≥96 hours.
  • Discharged to facility care.
  • Inability of outpatient follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clinico San Carlos

Madrid, 28040, Spain

RECRUITING

MeSH Terms

Conditions

EmergenciesHeart Failure

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHeart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Central Study Contacts

Francisco Javier Martín-Sánchez, MD, PhD.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Phase 1: Matched-pair cluster randomized clinical trial. Phase 2: a quasi-experimental study.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 28, 2018

First Posted

October 5, 2018

Study Start

May 20, 2019

Primary Completion

December 20, 2021

Study Completion

May 15, 2022

Last Updated

July 8, 2019

Record last verified: 2019-07

Locations